Ontario company seeks licence to make generic Johnson and Johnson COVID vaccine for developing countries

  • 📰 nationalpost
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 80%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

A compulsory licence can be granted when a company demonstrates a clear need for generic versions of patented medicine

AdvertisementBiolyse has sought and received a compulsory licence before, for the influenza drug Tamiflu during the H1N1 scare, but the process took seven months and the flu had largely run its course when it received approval. Compulsory licences were also issued to generic drug giant Apotex to send AIDS medications to Rwanda.

“If you can’t use a compulsory licence now, you can’t use Canada’s access to medicines regime now, then what’s the use?” Even with that licence, Johnson and Johnson would not be under any obligation to help Biolyse manufacture the vaccine, it just would have no recourse to stop it under patent law.Article content

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.

Who comes first. Canadians or developing countries. This covid19 has taught us one thing here in Canada. We have no Leadership in Ottawa, and JT always goes to China asking for help, instead of doing what GB did.

Developing countries At this point Canada is a Developing country with Trudeau's vaccine failure👎

Better idea: make it for the Canadian market as well.

Cool!

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 10. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인